| Antibiotic | Patients’ source* | |
| ICU | Other wards | |
| Cefepime |
|
|
| Sensitive | 26 (33.8) | 9 (60.0) |
| Intermediate | 7 (9.1) | 0 |
| Resistant | 44 (57.1) | 6 (40.0) |
| Ceftazidime |
|
|
| Sensitive | 19 (24.7) | 9 (60.0) |
| Intermediate | 5 (6.5) | 0 |
| Resistant | 53 (68.8) | 6 (40.0) |
| Piperacillin |
|
|
| Sensitive | 17 (22.1) | 9 (60.0) |
| Intermediate | 3 (3.9) | 0 |
| Resistant | 57 (74.0) | 6 (40.0) |
| Ticarcillin-clavulanate |
|
|
| Sensitive | 15 (19.5) | 7 (46.7) |
| Intermediate | 5 (6.5) | 2 (13.3) |
| Resistant | 57 (74.0) | 6 (40.0) |
| Aztreonam |
|
|
| Sensitive | 17 (22.1) | 8 (53.3) |
| Intermediate | 9 (11.7) | 1 (6.7) |
| Resistant | 51 (66.2) | 6 (40.0) |
| Levofloxacin |
|
|
| Sensitive | 27 (35.1) | 9 (60.0) |
| Intermediate | 3 (3.9) | 0 |
| Resistant | 47 (61.0) | 6 (40.0) |
| Ofloxacin |
|
|
| Sensitive | 0 | 3 (42.9) |
| Resistant | 11 (100.0) | 4 (57.1) |
| Meropenem |
|
|
| Sensitive | 15 (20.0) | 8 (53.3) |
| Intermediate | 2 (2.7) | 0 |
| Resistant | 58 (77.3) | 7 (46.7) |
| Imipenem |
|
|
| Sensitive | 25 (33.3) | 8 (53.3) |
| Resistant | 50 (66.7) | 7 (46.7) |